ROBINSON MATTHEW K 4
4 · Immunome Inc. · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Immunome Inc.IMNM
ROBINSON MATTHEW K
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-06-08+58,000→ 58,000 totalExercise: $4.84Exp: 2033-06-08→ Common Stock (58,000 underlying)
Footnotes (1)
- [F1]One-forty-eighth (1/48th) of the shares subject to such options shall vest monthly over forty-eight months after the grant date.